Preethi Sundaram, Chief Strategy Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 6,248 shares at $26.41 ($165K) on 2025-06-10, disclosed to the SEC on 2025-06-12.
Open-market sale of $165k CPRX by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.41 | 2,324 | $61K | 37.2% |
| 2 | $26.41 | 2,324 | $61K | 37.2% |
| 3 | $26.42 | 1,600 | $42K | 25.6% |
| Total | $26.41 avg | 6,248 | $165K | 100% |
| Filing → |